The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.


Author: Noel Lloyd

Date: January 21st, 2016

The threats Alzheimer's disease presents to the health and economic well-being of Americans have been well-documented. 

However, Alzheimer's isn't just a U.S. problem. It's a global challenge that threatens to create huge burdens for countries that have older adults as an increasing share of their overall population.

A new study published in the journal EBioMedicine takes a look at one such country: China.

The study's authors offer a troubling outlook for the country. They predict that the prevalence of the disease could quadruple by 2050, mainly due to increases in longevity.  The potential annual costs, which they deem as conservative, could top $1 trillion.

While the scenario they present isn't encouraging, they do note that there are ways to mitigate these impacts:

"Significant investment in research and development (medical and non-medical) is warranted and international researchers and national authorities should therefore target development of effective AD treatment and prevention strategies."

You can read the study here.  Also to learn more about the latest in Alzheimer's disease research, visit the ACT-AD Coalition website.


A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

Preventing the Flu: A Q & A with Dr. William Schaffner

Author: Noel Lloyd

Date: December 4th, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It